EM Vivas · Iron poisoning
Iron poisoning — stages, chelation and whole bowel irrigation viva
Clinical viva on iron poisoning severity markers, the five clinical phases, decontamination without charcoal, and desferrioxamine benefits and risks.
On this page
Study tools
Target exams
Interpretation
Reveal interpretationShowHide
Severity. An estimated ingestion of more than 60 mg/kg elemental iron, symptoms, hyperglycaemia above 150 mg/dL, leukocytosis above 15,000 and tablets on the radiograph indicate severe toxicity and the need for chelation.[1] Out of hospital, a known ingestion of 40 mg/kg or more of elemental iron as adult ferrous salts warrants referral.[2]
Phases. Five clinical phases are recognised: gastrointestinal toxicity, relative stability, circulatory shock and acidosis, hepatotoxicity, and gastrointestinal scarring.[4]
Decontamination. There is no role for activated charcoal in iron poisoning; whole bowel irrigation was recommended for iron salts.[5][3]
Chelation. Desferrioxamine infusion at 15 mg/kg/hour in saline; a "vin-rose" urine may help but is not seen consistently.[1] Prolonged intravenous dosing carries pulmonary and cardiovascular toxicity, and acute respiratory distress syndrome has been linked to desferrioxamine.[6][7]
References7ShowHide
- [1]Baranwal AK, Singhi SC. Acute iron poisoning: management guidelines. Indian Pediatrics, 2003.PMID 12824662
- [2]Manoguerra AS, et al. Iron ingestion: an evidence-based consensus guideline for out-of-hospital management. Clinical Toxicology, 2005.PMID 16255338
- [3]Tenenbein M The role of whole bowel irrigation in the treatment of toxic ingestions. British Journal of Clinical Pharmacology, 2023.PMID 36639859
- [4]Tenenbein M Toxicokinetics and toxicodynamics of iron poisoning. Toxicology letters, 1998.PMID 10022330
- [5]Hoegberg LCG, Gosselin S, Buckley NA, et al. Recommendations from the Clinical Toxicology Recommendations Collaborative on the administration of activated charcoal in acute oral overdose. Clinical toxicology (Philadelphia, Pa.), 2026.PMID 41906697
- [6]Howland MA Risks of parenteral deferoxamine for acute iron poisoning. Journal of toxicology. Clinical toxicology, 1996.PMID 8800186
- [7]Ioannides AS, Panisello JM Acute respiratory distress syndrome in children with acute iron poisoning: the role of intravenous desferrioxamine. European journal of pediatrics, 2000.PMID 10664227